Hard Tissue Augmentation With or Without Connective Tissue Graft in Immediate Esthetic Implants (NCT07333534) | Clinical Trial Compass
RecruitingNot Applicable
Hard Tissue Augmentation With or Without Connective Tissue Graft in Immediate Esthetic Implants
Iraq28 participantsStarted 2025-12-20
Plain-language summary
This randomized controlled study is aimed to evaluate the esthetic, clinical, and radiographic outcomes following the placement of immediate single-tooth implant with hard and soft tissue augmentation.
Subjects will randomly assigned to one of two groups:
* Group A (control group) receiving an immediate single-tooth implant in the esthetic zone with bone augmentation only.
* Group B (study group) receiving an immediate single-tooth implant in the esthetic zone with bone augmentation and connective tissue graft (CTG).
The main questions it aims to answer is:
Is there is a significant difference in the esthetic outcome between bone augmentation alone and bone augmentation combined with connective tissue graft after immediate dental implant in the esthetic zone?
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with a non-restorable tooth or a remaining root without signs of acute infection in the maxillary esthetic zone.
* The failing tooth is an incisor, canine or first bicuspid in the maxilla bounded by natural sound teeth.
* Sufficient bone (\>4 mm) apically and palatally to allow for proper implant positioning with sufficient primary stability (≥35 N cm).
* Sufficient mesial-distal and interocclusal space for placement of the implant and definitive restoration.
Exclusion Criteria:
* Patients with systemic conditions affecting bone healing (e.g., uncontrolled diabetes).
* Teeth with current acute periapical infection.
* Dehiscence of the labial (facial) bone plate after extraction.
* Signs of uncontrolled periodontal disease.
* Heavy smokers and vulnerable groups (pregnant females and decision-impaired individuals).
* History of head and neck radiation therapy.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pink Esthetic Score (PES)
Timeframe: Pink esthetic score (PES) will be assessed at 6 months postoperatively.